Koers Vycor Medical, Inc. Other OTC
Aandelen
VYCO
US92921M2035
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | 1,22 mln. 1,14 mln. | Omzet 2023 | 1,46 mln. 1,37 mln. | Marktkapitalisatie | 2,52 mln. 2,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 3,18 x |
Nettoschuld 2022 | 957K 896K | Nettoschuld 2023 | 1,05 mln. 986K | EV/omzet 2023 | 2,45 x |
K/w-verhouding 2022 |
-3,91
x | K/w-verhouding 2023 |
-6,39
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,09% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 14-05-10 |
President | 57 | 01-01-10 | |
Chairman | 65 | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peter Zachariou
CEO | Chief Executive Officer | 62 | 14-05-10 |
Chairman | 65 | 01-01-10 | |
President | 57 | 01-01-10 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,72% | 184 mld. | |
-2,60% | 107 mld. | |
-3,79% | 67,78 mld. | |
+2,66% | 50,66 mld. | |
+16,39% | 47,64 mld. | |
+4,60% | 41,12 mld. | |
+1,38% | 26,3 mld. | |
+1,52% | 26,04 mld. | |
+15,06% | 25,4 mld. |